CHEST 润色咨询

CHEST

出版年份:1970 年文章数:5788 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2024-03-23 文多多钱多多房多多 来自广东省

    偏重的研究方向:肺癌
    经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2024-02-27 ms3000001371147358 来自纽约

    with editor了快一周,是不是要悲剧

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2023-11-21 ms5000000021397414 来自山东省

    偏重的研究方向:重症
    经验分享:请教各位大神,个案报道好中么

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2023-04-09 ms7000001149694515 来自广东省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:临床营养学
    经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2022-01-29 godric

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:呼吸
    经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician.

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2022-06-06 ms8000000957503191

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:哮喘
    经验分享:投了第二天需要提交利益冲突说明

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2021-09-20 ms7000000117561646

    偏重的研究方向:胸科
    经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2022-05-11 sampondoc

    请问chest收综述吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2019-06-27 似水生

    major revison后接受了吗老师200750383 2015-08-14 19:20:00 发表:
    审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末
    自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试

    200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末
    自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2194805, encodeId=26e1219480596, content=偏重的研究方向:肺癌<br>经验分享:out with reviewers 超过三周了,这是什么情况,没有变成under review状态,是还没有人接受审稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Sat Mar 23 02:24:19 CST 2024, time=2024-03-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189682, encodeId=6e5b2189682fe, content=with editor了快一周,是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210726/6f642b4b4f4c468eb9a3480deeec025e/58beda36fbbc475192816be11c15587b.jpeg, createdBy=77405485873, createdName=ms3000001371147358, createdTime=Tue Feb 27 16:13:16 CST 2024, time=2024-02-27, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2169870, encodeId=2bfd21698e06b, content=偏重的研究方向:重症<br>经验分享:请教各位大神,个案报道好中么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18fa5634663, createdName=ms5000000021397414, createdTime=Tue Nov 21 07:16:47 CST 2023, time=2023-11-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2124527, encodeId=217c212452e50, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:临床营养学<br>经验分享:manuscript submitted保持了两周,然后第二天早上起床就看到被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67708207031, createdName=ms7000001149694515, createdTime=Sun Apr 09 00:55:35 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189123, encodeId=2b2f118912380, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:呼吸<br>经验分享:一审一个月,二审一个月,4 reviewers:3个临床医生(感觉)+ 1个statistician. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=735, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJX6b1UhVCmW07L3KzkJgF7hQxlEP69kwhC2RG8NYOCuiaVRAr23wkt7PtLkNf8d9IdbOC6uyNiaHOQ/132, createdBy=8dff2107976, createdName=godric, createdTime=Sat Jan 29 18:28:25 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224849, encodeId=a6841224849c0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:哮喘<br>经验分享:投了第二天需要提交利益冲突说明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae026507224, createdName=ms8000000957503191, createdTime=Mon Jun 06 22:23:33 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053259, encodeId=255d105325994, content=偏重的研究方向:胸科<br>经验分享:2021年8月19投的,投稿后7小时收到邮件填写利益冲突check list,第二天under review,现已外审一个月,还未有决策。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=709, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Sep 20 13:10:07 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218657, encodeId=8515121865e0d, content=请问chest收综述吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erKC7h2NdDTicyKPpmxR9DLzMIwLqbWUbiaB3Np7DG0IB7m1NFvRThT3dg4yXNicmzVyRjyngf4XgeGg/132, createdBy=5d8f1925951, createdName=sampondoc, createdTime=Wed May 11 09:05:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572998, encodeId=3c405e2998b8, content=major revison后接受了吗老师<span class="quote">200750383 2015-08-14 19:20:00 发表:<br>审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试</span>, beContent=200750383 2015-08-14 19:20:00 发表: 审稿速度不是一般的快,7月27号投稿,31号编辑处理,3号under review,6号Awaiting EIC decision,吓尿了,估计要悲剧了,6号晚上收到主编决定:Major revision,瞬间感动啊,你妈造吗,审稿速度真快,从投稿到结果才10天,中间8月1,2号还是周末 <br> 自己在上面发了不少文章,根据经验来说,不是特别容易发,比较难中,但是速度快,伙伴们可以试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/03/fa69411d4edfc5c95069eafc9ec0656a.jpg, createdBy=2f8d5093390, createdName=似水生, createdTime=Thu Jun 27 00:00:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811598, encodeId=7d66811598a6, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:胸科<br>经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=814, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Aug 20 22:52:51 CST 2020, time=2020-08-20, status=1, ipAttribution=)]
    2020-08-20 lovetcm

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:胸科
    经验分享:口碑一直不错,毕竟是官方期刊,同时审稿速度也很好

    4

    展开4条回复
共67条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分